According to the analysis of the Cancer Genome Atlas (TCGA) database, LOXL1 is expressed at elevated levels in breast cancer (p< 0.05), whereas LOXL4 is expressed at low levels (p < 0.05). Here, LOXL1 is linked to breast carcinoma.